Non-alcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Non-alcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Sonoelastography: Ultrasound Method to Measure Liver Fibrosis [NA]
A completed clinical trial evaluated sonoelastography, an ultrasound method to measure liver fibrosis; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: The Effect of an RBAC Supplement (BRM4) on NAFLD [NA]
A completed clinical trial evaluated the effect of the RBAC supplement BRM4 on Non-Alcoholic Fatty Liver Disease.
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Histological Improvement of NASH With Prebiotic [NA]
A completed clinical trial investigated histological improvement in non-alcoholic fatty liver disease (NASH) using a prebiotic therapy, sugg…
-
CLINICAL_TRIALS trial_result · 2017-06-12Clinical Trial Update: Autonomic Dysfunction in Non-Alcoholic Fatty Liver Disease
Clinical trial update notes completion of a study examining autonomic dysfunction in non-alcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2017-06-12Clinical Trial Update: Fatty Liver in Obesity: Long-lifestyle Follow-up (FLiO) [NA]
Trial registry update for the FLiO study (Fatty Liver in Obesity: Long-lifestyle Follow-up) evaluating Non-Alcoholic Fatty Liver Disease in …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Global Osteopathic Treatment for Patients With NAFLD [NA]
A clinical trial is evaluating global osteopathic treatment for patients with non-alcoholic fatty liver disease, but the current trial statu…
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Losartan in the Treatment of NAFLD in Children [Phase 2]
Phase 2 study evaluating Losartan for treating non-alcoholic fatty liver disease in children has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients [Phase 2]
Phase 2 trial evaluating amlexanox versus placebo in type 2 diabetes patients; results completed and posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Resveratrol for the Treatment of Non Alcoholic Fatty Liver Disease and Insulin Resistance in Overweight Adolescents [Phase 2, Phase 3]
This clinical trial update describes Phase 2/Phase 3 testing of resveratrol for overweight adolescents with NAFLD and insulin resistance. Th…
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant Recipients
Clinical trial update focusing on a non-invasive method to diagnose non-alcoholic steatohepatitis in liver transplant recipients.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in Youth [NA]
A completed clinical trial validating HepaFat-Scan as a noninvasive method to measure hepatic steatosis in youth with non-alcoholic fatty li…
-
CLINICAL_TRIALS withdrawal · 2017-03-30Clinical Trial Update: The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients [NA]
A clinical trial evaluating the effect of acetaminophen on patients with non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver Disease [NA]
A completed clinical trial evaluating whether a text messaging program can aid in the management of non-alcoholic fatty liver disease and no…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Antidiabetic Effects on Intrahepatic Fat [Phase 4]
A Phase 4 clinical trial investigating antidiabetic effects on intrahepatic fat in patients with non-alcoholic fatty liver disease and type …
-
CLINICAL_TRIALS trial_result · 2017-02-01Clinical Trial Update: Ultrasound Method to Measure Fibrosis of the Liver in Children [NA]
Update on a pediatric ultrasound method to measure liver fibrosis; the trial was terminated and results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: A Study to Investigate Effects of Omega-3 Carboxylic Acids and Dapagliflozin on Liver Fat Content in Diabetic Patients [Phase 2]
Phase 2 trial assessing the combined impact of Omega-3 carboxylic acids and dapagliflozin on liver fat content in patients with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: The Sleep, Liver Evaluation and Effective Pressure Study [Phase 2]
Phase 2 clinical trial update from Johns Hopkins University evaluating sleep, liver function, and pressure in non-alcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2016-11-22Clinical Trial Update: Dairy Fat as a Mediator of Vitamin E Adequacy in Individuals With Metabolic Syndrome [NA]
A completed clinical trial evaluated whether dairy fat affects vitamin E adequacy in people with metabolic syndrome, including non-alcoholic…
-
CLINICAL_TRIALS research · 2016-11-22Clinical Trial Update: Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD) [NA]
An interventional trial led by the German Institute of Human Nutrition investigates nutritional interventions for non-alcoholic fatty liver …
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: A Study of RO5093151 in Patients With Non-Alcoholic Fatty Liver Disease [Phase 1]
Phase 1 clinical trial update: RO5093151 for non-alcoholic fatty liver disease (NAFLD) conducted by Hoffmann-La Roche has completed. The ent…
-
CLINICAL_TRIALS research · 2016-10-27Clinical Trial Update: Epigenetic Mechanisms and Severe Obesity (Biological Tissue Collection)
This clinical trial investigates epigenetic mechanisms in severe obesity and involves collection of biological tissue; the study status is c…
-
CLINICAL_TRIALS trial_result · 2016-10-20Clinical Trial Update: Sitagliptin Versus Placebo in the Treatment of Non-alcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial comparing sitagliptin to placebo in non-alcoholic fatty liver disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2016-10-18Clinical Trial Update: Serine Supplementation for Obese Subjects With Fatty Liver Disease [Phase 1, Phase 2]
The clinical trial evaluating serine supplementation for obese individuals with non-alcoholic fatty liver disease has completed Phase 1 and …
-
CLINICAL_TRIALS withdrawal · 2016-09-30Clinical Trial Update: Non Alcoholic Fatty Liver Disease Influence of Statin Therapy [NA]
A clinical trial investigating the influence of statin therapy on non-alcoholic fatty liver disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: Safety Pilot Study of Farnesoid X Receptor (FXR) Agonist in Non-alcoholic Fatty Liver Disease (NAFLD) Patients [Phase 2]
A Phase 2 safety pilot study of a Farnesoid X Receptor (FXR) agonist in non-alcoholic fatty liver disease has completed.